Consumer DNA Testing Firm MyDNA Merges With Gene by Gene

Jan 07, 2021

|

NEW YORK — Direct-to-consumer DNA testing company MyDNA said on Thursday that it has merged with genetic testing firm Gene by Gene.

Houston, Texas-based Gene by Gene and its FamilyTreeDNA division, which were founded in 2000, offer a range of genetic testing services, including for ancestry, forensics, paternity, and, more recently, COVID-19. Melbourne, Australia-based MyDNA markets genetic wellness tests related to nutrition, fitness, and skincare.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Boosting Viral Surveillance

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

California Strain

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

Nucleic Acids Research Studies on Pan-Cancer MiRNA Biogenesis Mutations, Skeletal Methylation, More

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Featured White Papers

In-depth Quantification of Cell and Gene Therapy DNA Integrations Enabled with Single-cell Sequencing

Deep Understanding of Cell and Gene Therapy Genome Editing Protocols Enabled With Single-cell Sequencing

Illuminating the Role of the Adaptive Immune Response in Neurodegeneration

Transcriptional Profiling of 1.3 Million Brain Cells with the Chromium Single Cell Gene Expression Solution

Jan

26

Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Jan

28

Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.

Feb

11

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

17

Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Menu

Consumer DNA Testing Firm MyDNA Merges With Gene by Gene

To read the full story....

Breaking News

Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines

Bionano Genomics to Raise $200M in Public Stock Offering

CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

Interpace Bio Q3 Revenues Rise 6 Percent

Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

Predictive Oncology Prices $2.2M Direct Offering

The Scan

Boosting Viral Surveillance

California Strain

Nucleic Acids Research Studies on Pan-Cancer MiRNA Biogenesis Mutations, Skeletal Methylation, More

Lander Nominated for Science Advisor

Featured White Papers

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

What's Popular?

Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

Ancestry to Discontinue NGS-Based AncestryHealth Service

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection

Sponsorships